New Indication: Oral azacytidine for low-risk MDS
|New Indication: Oral azacytidine for low-risk MDS|
J Clin Oncol. Mar 25, 2021.
Garcia-Manero G, et al. Phase III, Randomized, Placebo-Controlled Trial of CC-486 (Oral Azacitidine) in Patients With Lower-Risk Myelodysplastic Syndromeshttps://doi.org/10.1200/JCO.20.02619
Altai Chemo Planner
Quickly Prepare Accurate Chemotherapy Orders
Altai Chemo Planner employs Altai Protocol Library that includes over 1000 chemotherapy protocols for both Hematology and Oncology. You can find major guidelines' protocols, parenteral, and oral, in the library. Altai Protocol Library is frequently and regularly updated.